{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:48:49Z","timestamp":1780375729333,"version":"3.54.1"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.critrevonc.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T03:46:15Z","timestamp":1463111175000},"page":"9-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations"],"prefix":"10.1016","volume":"104","author":[{"given":"S.","family":"Novello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Torri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ceresoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-063X","authenticated-orcid":false,"given":"A.","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Trodella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Facciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-9292","authenticated-orcid":false,"given":"A.","family":"Granieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Zagonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-958X","authenticated-orcid":false,"given":"G.","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2016.05.004_bib0005","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1378\/chest.120.6.1798","article-title":"Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma","volume":"120","author":"Adams","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0010","article-title":"Clinical safety and efficacy of pembrolizumab (MK-3475) in patients with malignant pleural mesothelioma: preliminary results from KEYNOTE-028","author":"Alley","year":"2015","journal-title":"Proc AACR Annual Meeting"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0015","series-title":"Pleural Mesothelioma. AJCC Cancer Staging Manual","first-page":"271","author":"American Joint Committee on Cancer","year":"2010"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0020","unstructured":"V ReNaM Report, 2015 (in press)"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0025","unstructured":"Anon, 2016. www.clinicaltrials.gov. Pemetrexed disodium or observation in treating patients with malignant pleural mesothelioma without progressive disease after first-line ClinicalTrials.gov Identifier NCT01085630."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0030","unstructured":"Anon, 2016. www.clinicaltrials.gov. Placebo controlled study of VS-6063 in subjects with malignant pleural mesothelioma (COMMAND) ClinicalTrials.gov Identifier NCT01870609."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0035","unstructured":"Anon, 2016 www.clinicaltrials.gov. Randomized, double-blind study comparing tremelimumab to placebo in subjects with unresectable malignant mesothelioma ClinicalTrials.gov Identifier Brozek."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0040","unstructured":"Anon, 2016. IOM documento di consenso sulle cure simultanee at www.aiom.it."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.lungcan.2013.08.005","article-title":"Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group","volume":"82","author":"Armato","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajim.20451","article-title":"Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature","volume":"50","author":"Ascoli","year":"2007","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.canep.2014.02.014","article-title":"Familial malignant mesothelioma: a population-based study in Central Italy (1980\u20132012)","volume":"38","author":"Ascoli","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2559.2008.03099.x","article-title":"The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma","volume":"53","author":"Attanoos","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0065","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0277-9536(01)00367-7","article-title":"The social and psychological impact of the chemical contamination incident in Weston Village, UK: a qualitative analysis","volume":"55","author":"Barnes","year":"2002","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11307-010-0426-6","article-title":"Current evidence base of FDG-PET\/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment","volume":"13","author":"Basu","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1037\/0003-066X.48.6.665","article-title":"Implications of psychological research on stress and technological accidents","volume":"48","author":"Baum","year":"1993","journal-title":"Am. Psychol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0080","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1756-0500-5-482","article-title":"Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience","volume":"5","author":"Bearz","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0085","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1002\/sim.2783","article-title":"Relative risk and acceleration in lung cancer","volume":"26","author":"Berry","year":"2007","journal-title":"Stat. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5858\/arpa.2010-0604-RA","article-title":"Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma","volume":"136","author":"Betta","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.22218","article-title":"Inference in germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area","volume":"54","author":"Betti","year":"2015","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0936-6555(05)80582-5","article-title":"The role of palliative radiotherapy in malignant mesothelioma","volume":"3","author":"Bissett","year":"1991","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"30","key":"10.1016\/j.critrevonc.2016.05.004_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11111-008-0075-8","article-title":"Proximate industrial activity and psychological distress","volume":"2008","author":"Boardman","year":"2008","journal-title":"Popul. Environ."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V","article-title":"Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: diagnosis","volume":"72","author":"Boutin","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy","volume":"108","author":"Boutin","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1752-699X.2011.00254.x","article-title":"Outcomes and complications following medical thoracoscopy","volume":"6","author":"Brims","year":"2012","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0125","series-title":"An unnatural death. A report into investigations of mesothelioma death and their impact on bereaved families","author":"British Lung Foundation","year":"2007"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0130","series-title":"Survey of people affected by mesothelioma 2013","author":"British Lung Foundation","year":"2013"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0135","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.athoracsur.2004.05.007","article-title":"Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma","volume":"78","author":"Bueno","year":"2004","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(13)70125-6","article-title":"Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study","volume":"14","author":"Buikhuisen","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjc.6601957","article-title":"A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma","volume":"91","author":"Bydder","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0155","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S1470-2045(13)70381-4","article-title":"Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial","volume":"14","author":"Calabr\u00f2","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0160","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","article-title":"Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials","volume":"99","author":"Ceresoli","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2010.12.004","article-title":"Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma","volume":"72","author":"Ceresoli","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/bjc.2014.312","article-title":"Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey","volume":"111","author":"Ceresoli","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2217\/lmt.14.17","article-title":"Second line treatment in malignant pleural mesothelioma: translating the evidence into clinical practice","volume":"3","author":"Ceresoli","year":"2014","journal-title":"Lung Cancer Manage."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijrobp.2014.08.343","article-title":"Hemithoracic intensity modulated radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis","volume":"91","author":"Chance","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0190","series-title":"Research Methods in Occupational Epidemiology","first-page":"163","author":"Checkoway","year":"2004"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0195","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/annonc\/mdp318","article-title":"European society of medical oncology (ESMO) program for the integration of oncology and palliative care: a 5-year review of the designated centers\u2019 incentive program","volume":"21","author":"Cherny","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","article-title":"Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma","volume":"206","author":"Cheung","year":"2013","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0205","series-title":"Pathology & Genetics: Tumours of the Lung Pleura, Thymus and Heart","first-page":"128","article-title":"Mesothelioma","author":"Churg","year":"2004"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0210","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0215","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","article-title":"Tumours of the pleura: mesothelial tumours","author":"Churg","year":"2015"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0220","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","author":"Cigognetti","year":"2015","journal-title":"Mod. Pathol."},{"issue":"S1","key":"10.1016\/j.critrevonc.2016.05.004_bib0225","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2105\/AJPH.2010.300039","article-title":"Community stress, psychosocial hazards, and EPA decision-Making in communities impacted by chronic technological disasters","volume":"101","author":"Couch","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0230","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0235","doi-asserted-by":"crossref","first-page":"413946","DOI":"10.1155\/2014\/413946","article-title":"Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma","volume":"2014","author":"Creaney","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0240","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thoraxjnl-2014-205205","article-title":"Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma","volume":"69","author":"Creaney","year":"2014","journal-title":"Thorax"},{"issue":"56","key":"10.1016\/j.critrevonc.2016.05.004_bib0245","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0277-9536(02)00054-0","article-title":"Impacts of an environmental disaster on psychosocial health and well-being in Karakalpakstan","volume":"2003","author":"Crighton","year":"2003","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0250","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/002214650504600306","article-title":"Environmental stressors the mental health impacts of living near industrial activity","volume":"46","author":"Downey","year":"2005","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1037\/h0099382","article-title":"The deepwater horizon oil spill and the Mississippi Gulf coast: mental health in the context of a technological disaster","volume":"84","author":"Drescher","year":"2014","journal-title":"Am. J. Orthopsychiatry"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0260","first-page":"232","article-title":"The role of key genes and pathways involved in the tumorigenesis of malignant mesothelioma","volume":"1845","author":"de Assis","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0265","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ijc.27758","article-title":"Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia","volume":"132","author":"de Klerk","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0270","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jtcvs.2004.10.034","article-title":"Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications","volume":"129","author":"Erasmus","year":"2005","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma","volume":"5","author":"Fennell","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0280","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ajim.22063","article-title":"Malignant mesothelioma incidence among talc miners and millers in New York State","volume":"55","author":"Finkelstein","year":"2012","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0285","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores Pass","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5223(03)00207-1","article-title":"Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma","volume":"126","author":"Flores","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0295","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0360-3016(02)04150-0","article-title":"Intensity modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation","volume":"55","author":"Forster","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10903-006-9024-8","article-title":"Chernobyl disaster sequelae in recent immigrants to the United States from the former Soviet Union (FSU)","volume":"9","author":"Foster","year":"2007","journal-title":"J. Immigr. Minor. Health"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0305","first-page":"7425","article-title":"Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology","volume":"34","author":"Franceschini","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0310","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1183\/09031936.00146110","article-title":"Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma","volume":"38","author":"Frauenfelder","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0315","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12094-011-0617-x","article-title":"Clinical-therapeutic management of thoracoscopy in pleural effusion: a groundbreaking technique in the twentyfirst century","volume":"13","author":"Galbis","year":"2011","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.publhealth.28.021406.144123","article-title":"Risk communication for public health emergencies","volume":"28","author":"Glik","year":"2007","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0325","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11864-014-0314-4","article-title":"Local and systemic therapies for malignant pleural mesothelioma","volume":"4","author":"Gomez","year":"2014","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0330","first-page":"1193","article-title":"Quality of life and personality traits in patients with malignant pleural mesothelioma and their first-degree caregivers","volume":"9","author":"Granieri","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat. J."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0335","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1289\/ehp.1002915","article-title":"The early psychological impacts of the Deepwater Horizon oil spill on Florida and Alabama communities","volume":"119","author":"Grattan","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0340","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/cncr.23034","article-title":"Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma","volume":"110","author":"Greillier","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0345","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S1470-2045(14)71109-X","article-title":"Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes","volume":"15","author":"Grosse","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0350","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3389\/fpsyg.2014.01419","article-title":"Helping traumatized people survive: a psychoanalytic intervention in a contaminated site","volume":"5","author":"Guglielmucci","year":"2014","journal-title":"Front. Psychol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0355","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/thoraxjnl-2014-206054","article-title":"Role of CT in assessing pleural malignancy prior to thoracoscopy","volume":"70","author":"Hallifax","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0360","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejso.2004.08.014","article-title":"Improved survival with VATS pleurectomy\u2014decortication in advanced malignant mesothelioma","volume":"31","author":"Halstead","year":"2005","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0365","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0954-6111(98)90100-7","article-title":"Medical thoracoscopy, results and complications in 146 patients: a retrospective study","volume":"92","author":"Hansen","year":"1998","journal-title":"Respir. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0370","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1158\/1078-0432.CCR-14-0804","article-title":"Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma","volume":"20","author":"Hassan","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0375","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers","volume":"66","author":"Henderson","year":"2013","journal-title":"J. Clin. Pathol."},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2016.05.004_bib0380","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jclinpath-2013-201609","article-title":"Challenges and controversies in the diagnosis of malignant mesothelioma: part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA","volume":"66","author":"Henderson","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000377697","volume":"59","author":"Hjerpe","year":"2015","journal-title":"Acta Cytol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0390","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","article-title":"Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma","volume":"181","author":"Hollevoet","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0395","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","article-title":"Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma","volume":"6","author":"Hollevoet","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2016.05.004_bib0400","first-page":"ii4","article-title":"Investigation of a unilateral pleural effusion in adults: british thoracic society pleural disease guideline 2010","volume":"65","author":"Hooper","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2014-0312","article-title":"Integration of Oncology and palliative care: a systematic review","volume":"20","author":"Hui","year":"2015","journal-title":"Oncologist"},{"issue":"Pt. C","key":"10.1016\/j.critrevonc.2016.05.004_bib0410","first-page":"11","article-title":"Arsenic, metals, fibres, and dusts. IARC working group on the evaluation of carcinogenic risks to humans","volume":"100","author":"IARC International Agency for Research on Cancer (IARC)","year":"2012","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0415","series-title":"Communication at International Conference on Monitoring and Surveillance of Asbestos-related Diseases Proceedings Book 2014","article-title":"Economic burden of Mesothelioma in Italy","author":"Iavicoli","year":"2014"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0420","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.09.9887","article-title":"Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma","volume":"26","author":"Jassem","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0425","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncy.21392","article-title":"Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology","volume":"122","author":"Jo","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0430","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/JTO.0b013e31820ce2c7","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"Kao","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"October. (2)","key":"10.1016\/j.critrevonc.2016.05.004_bib0435","first-page":"S39","article-title":"Pulmonary pathology: SY22-2 diagnosis of mesothelioma using japanese criteria","volume":"46","author":"Kawai","year":"2014","journal-title":"Pathology (Phila.)"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0440","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2011.41.5869","article-title":"Multi-center, double-blind, placebo- controlled, randomized phase II trial of gemcitabine\/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma","volume":"30","author":"Kindler","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.05.004_bib0445","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1470-2045(15)70056-2","article-title":"Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"16","author":"Krug","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0450","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/annonc\/mds535","article-title":"Armato SG 3rd: disease volumes as a marker for patient response in malignant pleural mesothelioma","volume":"24","author":"Labby","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0455","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/JTO.0b013e31828354c8","article-title":"Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma","volume":"8","author":"Labby","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0460","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","article-title":"et al: new strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment","volume":"18","author":"Ladanyi","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0465","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/JTO.0b013e31824ab6c5","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0470","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/(SICI)1097-0274(199903)35:3<246::AID-AJIM4>3.0.CO;2-6","article-title":"Latency analysis in epidemiologic studies of occupational exposures: application to the Colorado Plateau uranium miners cohort","volume":"35","author":"Langholz","year":"1999","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0475","first-page":"364","article-title":"Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases","volume":"43","author":"Lao","year":"2014","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0480","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/PAS.0b013e3182910c82","article-title":"Diffuse intrapulmonary malignant mesothelioma masquerading as interstitial lung disease: a distinctive variant of mesothelioma","volume":"37","author":"Larsen","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0485","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1183\/09031936.96.09122565","article-title":"Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: a nonrandomized phase II study","volume":"9","author":"Lind\u00e9n","year":"1996","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.05.004_bib0490","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dc.21380","article-title":"Usefulness of claudin 4 in the cytologic al diagnosis of serosal effusions","volume":"39","author":"Lonardi","year":"2011","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0495","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/1055-9965.EPI-05-0863","article-title":"Cigarette smoking and lung cancer: modeling total exposure and intensity","volume":"15","author":"Lubin","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0500","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.rmed.2009.05.017","article-title":"Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis","volume":"104","author":"Luo","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0505","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/JTO.0000000000000499","article-title":"Is radiotherapy useful for treating pain in mesothelioma?: a phase II trial","volume":"10","author":"MacLeod","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0510","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1010-7940(01)00995-2","article-title":"Palliative surgical debulking in malignant mesothelioma: predictors of survival and symptom control","volume":"20","author":"Martin-Ucar","year":"2001","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0515","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(03)13079-6","article-title":"Standard pleural biopsy versus CT guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial","volume":"361","author":"Maskell","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0520","first-page":"337","article-title":"A rare occupation causing mesothelioma: mechanisms and differential etiology","volume":"105","author":"Mastrangelo","year":"2014","journal-title":"Med. Lav."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0525","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1378\/chest.09-0884","article-title":"Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial","volume":"137","author":"Metintas","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0530","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1378\/chest.09-0884","article-title":"Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial","volume":"137","author":"Metintas","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0535","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2013.10.013","article-title":"Radical pleurectomy\/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up","volume":"83","author":"Minatel","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0540","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","article-title":"Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial","volume":"17","author":"Muers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0545","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejcts.2007.09.039","article-title":"The role of video-assisted thoracoscopic pleurectomy\/decortication in the therapeutic management of malignant pleural mesothelioma","volume":"33","author":"Nakas","year":"2008","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0550","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ejcts\/ezr251","article-title":"The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma","volume":"42","author":"Nakas","year":"2012","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0555","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1148\/rg.346130089","article-title":"Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma","volume":"34","author":"Nickell","year":"2014","journal-title":"Radiographics"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0560","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/h0087153","article-title":"The Tar Ponds kids: toxic environments and adolescent well-being","volume":"34","author":"O\u2019Leary","year":"2002","journal-title":"Can. J. Behav. Sci."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0565","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2007.05.022","article-title":"A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma","volume":"84","author":"O'Rourke","year":"2007","journal-title":"Radiother. Oncol."},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2016.05.004_bib0570","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/modpathol.2012.105","article-title":"Deciduoid mesothelioma: report of 21 cases with review of the literature","volume":"25","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0575","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/modpathol.2011.202","article-title":"Mesotheliomas with small cell features: report of eight cases","volume":"25","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Mod. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2016.05.004_bib0580","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2012.39","article-title":"Pleomorphic mesothelioma: report of 10 cases","volume":"25","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Mod. Pathol."},{"issue":"Marh (3)","key":"10.1016\/j.critrevonc.2016.05.004_bib0585","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2012.172","article-title":"Mesothelioma with signet-ring cell features: report of 23 cases","volume":"26","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2012.05.014","article-title":"Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update","volume":"44","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0595","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncy.21342","article-title":"The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey","volume":"121","author":"Paintal","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0600","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1521\/psyc.2012.75.3.203","article-title":"A conceptual framework for understanding the mental health impacts of oil spills: lessons from the Exxon Valdez oil spill","volume":"75","author":"Palinkas","year":"2012","journal-title":"Psychiatry"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0605","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2013.54.8149","article-title":"Developing a service model that integrates palliative care throughout cancer care: the time is now","volume":"32","author":"Partridge","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"7387","key":"10.1016\/j.critrevonc.2016.05.004_bib0610","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(65)91824-6","article-title":"Age at onset of lung cancer: significance in relation to effect of smoking","volume":"1","author":"Pike","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0615","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/COC.0b013e3181d31f02","article-title":"Expert opinions of the first Italian consensus conference on the management of malignant pleural mesothelioma","volume":"34","author":"Pinto","year":"2011","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0620","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ctrv.2012.11.004","article-title":"Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations","volume":"39","author":"Pinto","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0625","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1539-6924.2005.00643.x","article-title":"Mesothelioma: risk apportionment among asbestos exposure sources","volume":"25","author":"Price","year":"2005","journal-title":"Risk Anal."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0630","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccm.2006.02.001","article-title":"Imaging of pleural disease","volume":"27","author":"Qureshi","year":"2006","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0635","unstructured":"Registro Nazionale Mesoteliomi (ReNaM), 2012 Quarto Rapporto Edizioni INAIL Roma."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0640","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/thoraxjnl-2013-204161","article-title":"Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis","volume":"69","author":"Reid","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0645","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijrobp.2007.03.011","article-title":"Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"69","author":"Rice","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0650","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.athoracsur.2009.05.022","article-title":"Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma","volume":"88","author":"Rice","year":"2009","journal-title":"Ann. Thorac. Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2016.05.004_bib0655","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0660","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/cncr.24886","article-title":"Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases","volume":"116","author":"Richards","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0665","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/EDE.0b013e31826c3149","article-title":"Regression models for the effects of exposure rate and cumulative exposure","volume":"23","author":"Richardson","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0670","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleural intensity modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0675","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","article-title":"A phase II trial of surgical resection and adjuvant high-dose hemothoracic radiation for malignant pleural mesothelioma","volume":"122","author":"Rusch","year":"2001","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0680","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ejcts.2008.07.050","article-title":"Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-d-glucose positron emission tomography\/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy","volume":"34","author":"S\u00f8rensen","year":"2008","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0685","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","article-title":"Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemona\u0131ve patients with malignant pleural mesothelioma: results of the international expanded access program","volume":"3","author":"Santoro","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0690","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4329\/wjr.v5.i10.372","article-title":"Contrast-enhanced ultrasonography in peripheral lung consolidations: what's its actual role","volume":"5","author":"Sartori","year":"2013","journal-title":"World J. Radiol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0695","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0700","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"Br. Med. J."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0705","first-page":"1","article-title":"The Diagnosis of thoracic malignant mesothelioma: practical considerations and recent developments","volume":"30","author":"Smith","year":"2014","journal-title":"Turk. Patoloji Derg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0710","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1200\/JCO.2011.38.5161","article-title":"American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care","volume":"30","author":"Smith","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"S5","key":"10.1016\/j.critrevonc.2016.05.004_bib0715","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/annonc\/mdu438.65","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy (EPP) of malignant pleural mesothelioma (MPM) with or without hemithoracic radiotherapy: final results of the randomized multicenter phase II trial SAKK17\/04","volume":"25","author":"Stahel","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0720","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdv101","article-title":"Searching for targets for the systemic therapy of mesothelioma","author":"Stahel","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0725","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","article-title":"Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients","volume":"260","author":"Sugarbaker","year":"2014","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0730","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0971-3026.125577","article-title":"Radiological review of pleural tumors","volume":"23","author":"Sureka","year":"2013","journal-title":"Indian J. Radiol. Imaging"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0735","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0740","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0745","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/aje\/kwt274","article-title":"Invited commentary is it time to retire the pack-years variable? Maybe Not!","volume":"179","author":"Thomas","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0750","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1158\/1078-0432.CCR-07-5283","article-title":"Transesophageal endoscopic ultrasound with fine needle aspiration in the preoperative staging of malignant pleural mesothelioma","volume":"14","author":"Tournoy","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0755","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ejcts\/ezu001","article-title":"Surgery for malignant pleural mesothelioma: why we need controlled trials","volume":"45","author":"Treasure","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0760","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.ro.2013.03.017","article-title":"Malignant pleural mesothelioma: role of CT, MRI, and PET\/CT in staging evaluation and treatment considerations","volume":"48","author":"Truong","year":"2013","journal-title":"Semin. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0765","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.ro.2013.03.017","article-title":"Malignant pleural mesothelioma: role of CT, MRI, and PET\/CT in staging evaluation and treatment considerations","volume":"48","author":"Truong","year":"2013","journal-title":"Semin. Roentgenol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0770","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"Van Meerbeeck","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0775","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/aje\/kwt273","article-title":"Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY study","volume":"179","author":"Vlandereen","year":"2013","journal-title":"Am J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0780","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0785","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1556-0864(15)31509-4","article-title":"Pemetrexed maintenance therapy in patients with malignant pleural mesothelioma","volume":"1","author":"van den Bogaert","year":"2006","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0790","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1378\/chest.107.5.1454","article-title":"Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion","volume":"107","author":"Waller","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0795","doi-asserted-by":"crossref","first-page":"e114483","DOI":"10.1371\/journal.pone.0114483","article-title":"Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis","volume":"9","author":"Weber","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0800","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1200\/JCO.2009.26.9944","article-title":"Soluble mesothelin-related peptide and osteopontin as markers of response in malignant mesothelioma","volume":"28","author":"Wheatley-Price","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0805","series-title":"Air Quality Guidelines for Europe Copenhagen 2000","author":"World Health Organization Regional Office for Europe","year":"2000"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0810","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0815","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1510\/icvts.2010.255893","article-title":"What is the best way to diagnose and stage malignant pleural mesothelioma","volume":"12","author":"Zahid","year":"2011","journal-title":"Interact Cardiovasc. Thorac. Surg."},{"issue":"Suppl. 15","key":"10.1016\/j.critrevonc.2016.05.004_bib0820","article-title":"IFCT-GFPC-0701 MAPS trial, a multicenter randomized phase II\/III trial of pemetrexed-cisplatin with or without bevacizumab in patients with malignant pleural mesothelioma","volume":"28","author":"Zalcman","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2016.05.004_bib0825","article-title":"Bevacizumab 15mg\/kg plus cisplatin-pemetrexed (CP) triplet versus CP doublet in malignant pleural mesothelioma (MPM): results of the IFCT-GFPC-0701 MAPS randomized phase 3 trial","volume":"33","author":"Zalcman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0830","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1510\/icvts.2009.213611","article-title":"Staging algorithm for diffuse malignant pleural mesotelioma","volume":"10","author":"Zielinski","year":"2010","journal-title":"Interact Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0835","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.lungcan.2011.08.011","article-title":"Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey","volume":"75","author":"Zucali","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2016.05.004_bib0840","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J. Thorac. Dis."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281630110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084281630110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T19:45:28Z","timestamp":1600544728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084281630110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":168,"alternative-id":["S104084281630110X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.05.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}